T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.
暂无分享，去创建一个
Michael L. Wang | M. Stetler-Stevenson | D. Stroncek | Judith Lawrence | S. Feldman | S. Pavletic | J. Kochenderfer | I. Maric | R. Gress | F. Hakim | C. Yuan | Rashmika Patel | Norris Lam | Jennifer N Brudno | S. A. Ali | J. Rose | Dalia A. Salem | L. Mikkilineni | B. Hansen | J. Kanakry | Steven D. Hartman | Steven D Hartman | Jennifer N. Brudno